Where the Pathways Conversation Turns to Action


Results of a large study supported by the National Cancer Institute found that patients who survived testicular cancer are at a higher risk of developing heart disease.
A recent study examined a potential association between system-level integration and longitudinal costs of cancer care.
Socioeconomic inequalities may affect cancer-specific survival and overall survival in patients with squamous cell carcinoma of the anus.
Treatment with a BTK inhibitor has been shown to yield good depth and duration of response in patients with chronic lymphocytic leukemia, regardless of TP53 status.
A recent study assessed whether combining a targeted therapy with an immunotherapy for ALK translocation-positive advanced non-small cell lung cancer results in more durable patient responses.
Recent efforts to develop and validate a patient-reported assessment of the quality of palliative cancer care have been successful.
Long-term data show that a CAR-T therapy induces significant clinical benefit without added adverse events among patients with refractory aggressive non-Hodgkin lymphoma.
A new study suggests the strength of evidence cited by the National Comprehensive Cancer Network to support recommendations deviating from FDA-approved therapy recommendations is not robust.
Health care resource use and approaches to clinical management of advanced non-small cell lung cancer vary significantly in eight different countries.